Neurofilament ELISA validation
Author
Hintzen, Rogier
Norgren, Niklas
Papuc, Eva
Paraskevas, George P.
Pirttila, Tuula
Rajda, Cecilia
Rejdak, Konrad
Ricny, Jan
Ripova, Daniela
Rosengren, Lars
Ruggieri, Maddalena
Schraen, Susanna
Shaw, Gerry
Sindic, Christian
Siva, Aksel
Stigbrand, Torgny
Stonebridge, Iva
Topcular, Baris
Trojano, Maria
Tumani, Hayrettin
Twaalfhoven, Harry A. M.
Vecsei, Laszlo
Van Pesch, Vincent
Vanderstichele, Hugo
Vedeler, Christian
Verbeek, Marcel M.
Maria Villar, Luisa
Weissert, Robert
Wildemann, Brigitte
Yang, Cui
Yao, Karen
Teunissen, Charlotte E.
Altintas, Ayse
Deniz, Gunnur
Erten, Gaye
Petzold, Axel
Andreoni, Laura
Bartos, Ales
Berthele, Achim
Blankenstein, Marinus A.
Buee, Luc
Castellazzi, Massimiliano
Cepok, Sabine
Comabella, Manuel
Constantinescu, Cris S.
Deisenhammer, Florian
Espino, Mercedes
Fainardi, Enrico
Franciotta, Diego
Freedman, Mark S.
Giedraitis, Vilmantas
Gilhus, Nils Erik
Giovannoni, Gavin
Glabinski, Andrzej
Grieb, Pawel
Hartung, Hans-Peter
Hemmer, Bernhard
Herukka, Sanna-Kaisa
Ingelsson, Martin
Jackson, Samuel
Jacobsen, Steve
Jafari, Naghmeh
Jalosinski, Marcin
Jarius, Sven
Kapaki, Elisabeth
Kieseier, Bernd C.
Koel-Simmelink, Marleen J. A.
Kornhuber, Johannes
Kuhle, Jens
Kurzepa, Jacek
Lalive, Patrice H.
Lannfelt, Lars
Lehmensiek, Vera
Lewczuk, Piotr
Livrea, Paolo
Marnetto, Fabiana
Martino, Davide
Menge, Til
Metadata
Show full item recordAbstract
Background: Neurofilament proteins (Nf) are highly specific biomarkers for neuronal death and axonal degeneration. As these markers become more widely used, an inter-laboratory validation study is required to identify assay criteria for high quality performance.
Collections
- Makale [92796]